Klaus Dugi

Klaus Dugi is currently the Director at AOBiome Therapeutics. Prior to this, they served as the Executive Vice President and Chief Medical Officer at Ferring Pharmaceuticals from October 2017 to December 2020. Klaus was also a member of the Executive Board of Ferring Pharmaceuticals during their tenure. Klaus has also worked with Boehringer Ingelheim in various capacities such as Chief Medical Officer, Corporate Vice President Medical Affairs, and Vice President Therapeutic Area Metabolic Diseases from January 2010 to July 2015, July 2008 to December 2009, and July 2006 to June 2008 respectively. Klaus has also served as the Managing Director UK & Ireland at Boehringer Ingelheim Limited UK from August 2015 to September 2017. Klaus started their career as an Attending Physician at Med. Univ.Klinik. Heidelberg from January 2001 to December 2002.